BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12834850)

  • 1. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
    Chakraborty H; Banerjee R; Sarkar M
    Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of piroxicam with micelles: effect of hydrophobic chain length on structural switchover.
    Chakraborty H; Sarkar M
    Biophys Chem; 2005 Aug; 117(1):79-85. PubMed ID: 15908103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
    Chakraborty H; Roy S; Sarkar M
    Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
    Banerjee R; Chakraborty H; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical spectroscopic and TEM studies of catanionic micelles of CTAB/SDS and their interaction with a NSAID.
    Chakraborty H; Sarkar M
    Langmuir; 2004 Apr; 20(9):3551-8. PubMed ID: 15875383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
    Mondal Roy S; Sarkar M
    Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of non-steroid anti-inflammatory drugs in membrane bilayers.
    Kyrikou I; Hadjikakou SK; Kovala-Demertzi D; Viras K; Mavromoustakos T
    Chem Phys Lipids; 2004 Dec; 132(2):157-69. PubMed ID: 15555602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drug induced membrane fusion: concentration and temperature effects.
    Mondal S; Sarkar M
    J Phys Chem B; 2009 Dec; 113(51):16323-31. PubMed ID: 19954169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
    Chakraborty S; Bose M; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Mismatches in Fatty Acyl Tail Lengths Can Effect Non Steroidal Anti-Inflammatory Drug Induced Membrane Fusion.
    Majumdar A; Sarkar M
    J Phys Chem B; 2016 Jun; 120(21):4791-802. PubMed ID: 27153337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
    Roy S; Banerjee R; Sarkar M
    J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Oxicam NSAIDs with lipid monolayer: anomalous dependence on drug concentration.
    Kundu S; Chakraborty H; Sarkar M; Datta A
    Colloids Surf B Biointerfaces; 2009 Apr; 70(1):157-61. PubMed ID: 19157803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micellar dipolar rearrangement is sensitive to hydrophobic chain length: Implication for structural switchover of piroxicam.
    Sethy D; Chakraborty H
    Chem Phys Lipids; 2016 Oct; 200():120-125. PubMed ID: 27680423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
    Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
    J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reactions of oxicam and sulfoanilide non steroidal anti-inflammatory drugs with hypochlorous acid: determination of the rate constants with an assay based on the competition with para-aminobenzoic acid chlorination and identification of some oxidation products.
    Van Antwerpen P; Dubois J; Gelbcke M; Neve J
    Free Radic Res; 2004 Mar; 38(3):251-8. PubMed ID: 15129733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced and long-term degradation assays of tenoxicam, piroxicam and meloxicam in river water. Degradation products and adsorption to sediment.
    Jiménez JJ; Muñoz BE; Sánchez MI; Pardo R
    Chemosphere; 2018 Jan; 191():903-910. PubMed ID: 29145135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-guest complexation of oxicam NSAIDs with beta-cyclodextrin.
    Banerjee R; Chakraborty H; Sarkar M
    Biopolymers; 2004 Nov; 75(4):355-65. PubMed ID: 15372483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of piroxicam and meloxicam with DMPG/DMPC mixed vesicles: anomalous partitioning behavior.
    Chakraborty H; Sarkar M
    Biophys Chem; 2007 Feb; 125(2-3):306-13. PubMed ID: 17010502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination for oxicam non-steroidal anti-inflammatory drugs in human serum by liquid chromatography-tandem mass spectrometry.
    Shirako J; Kawasaki M; Komine K; Kunisue Y; Terada M; Sasaki C; Irie W; Murakami C; Tonooka K; Tomobe K; Shinozuka T
    Forensic Sci Int; 2013 Apr; 227(1-3):100-2. PubMed ID: 23273940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane fusion: a new function of non steroidal anti-inflammatory drugs.
    Chakraborty H; Mondal S; Sarkar M
    Biophys Chem; 2008 Sep; 137(1):28-34. PubMed ID: 18617319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.